Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. [electronic resource]
Producer: 20080221Description: G236-44 p. digitalISSN:- 0193-1857
- Administration, Inhalation
- Alanine Transaminase -- blood
- Animals
- Apoptosis Regulatory Proteins -- genetics
- Carbon Monoxide -- administration & dosage
- Carboxyhemoglobin -- metabolism
- Cold Ischemia -- adverse effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Down-Regulation
- Heme Oxygenase (Decyclizing) -- genetics
- Interleukin-6 -- genetics
- Liver -- drug effects
- Liver Transplantation -- adverse effects
- MAP Kinase Kinase 1 -- metabolism
- MAP Kinase Kinase 2 -- metabolism
- MAP Kinase Kinase Kinases -- metabolism
- Male
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Necrosis
- Neutrophil Infiltration -- drug effects
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type II -- genetics
- Phosphorylation
- Protective Agents -- administration & dosage
- Proto-Oncogene Proteins c-myc -- metabolism
- RNA, Messenger -- metabolism
- Rats
- Rats, Inbred Lew
- Reperfusion Injury -- enzymology
- STAT Transcription Factors -- metabolism
- Time Factors
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.